Biography
Dr. Feng Long is a distinguished Director of Medical Oncology at Second Affiliated Hospital, Zhejiang University with 17 years of dedicated clinical practice. Over the course of an extensive career, Feng Long has treated thousands of international and domestic patients, establishing a reputation for clinical excellence, evidence-based decision-making, and compassionate, family-centered care.
Clinical Focus & Expertise
Dr. Feng Long specializes in the diagnosis and management of complex medical conditions, with particular expertise in Breast cancer, Targeted therapy, Lymphoma, Immunotherapy. The clinical practice combines current best-evidence medicine with personalized treatment planning — recognizing that every patient brings a unique medical history, lifestyle, and set of life priorities to the consultation room.
Conditions Treated
Patients consult Dr. Feng Long for the following conditions and procedures:
- Breast cancer
- Targeted therapy
- Lymphoma
- Immunotherapy
Education & Training
- MD/PhD Tsinghua University · Fellowship MD Anderson Cancer Center
Professional Credentials & Memberships
- European Society for Medical Oncology (ESMO)
- American Society of Clinical Oncology (ASCO) Affiliate
- International Association for the Study of Lung Cancer
International Patient Care
Dr. Feng Long communicates with patients in English, Chinese, Korean, providing direct rapport without the need for translation in those languages. The hospital's international department coordinates dedicated case managers, multilingual interpreters for additional languages, simplified visa documentation, and personalized treatment itineraries for travelers from over 60 countries.
“Every patient deserves more than a diagnosis — they deserve a treatment plan that respects who they are, where they come from, and what matters most to them.”
Education
MD/PhD Tsinghua University · Fellowship MD Anderson Cancer Center
Certifications
- European Society for Medical Oncology (ESMO)
- American Society of Clinical Oncology (ASCO) Affiliate
- International Association for the Study of Lung Cancer